Novel methods for disinfection of prion-contaminated medical devices

Lancet

Volumn 364, Issue 9433, 2004, Pages 521-526

  Fichet, Guillaume ^a,b   Comoy, Emmanuel ^a   Duval, Christelle ^a,d   Antloga, Kathleen ^c   Dehen, Capucine ^a   Charbonnier, Aurore ^a   McDonnell, Gerald ^c   Brown, Paul ^e   Ida Lasmézas, Corinne ^a   Deslys, Jean Philippe ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b Anjou Recherche   (France)

^c STERIS Ltd   (United Kingdom)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e Bethesda ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; HYDROGEN PEROXIDE; PHENOL DERIVATIVE; PRION PROTEIN; SODIUM CHLORIDE; SODIUM HYDROXIDE; STAINLESS STEEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCLAVE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISINFECTION; FEMALE; HIGH TEMPERATURE; IN VIVO CULTURE; INSTRUMENT STERILIZATION; LETHAL DOSE; MEDICAL INSTRUMENTATION; NONHUMAN; PRION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS STRAIN;

EID: 4043153397     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16810-4     Document Type: Article

References (27)

1. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet. 358:2001;171-180
2. Head MW, Ritchie D, Smith N, et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol. 164:2004;143-153
3. Herzog C, Sales N, Etchegaray N, et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet. 363:2004;422-428
4. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 363:2004;417-421
5. Gibbs CJ Jr, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC. Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry. 57:1994;757-758
6. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 35:1994;513-529
7. Brown P, Rohwer RG, Gajdusek DC. Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus. N Engl J Med. 310:1984;727
8. Taylor DM, Fraser H, McConnell I, et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol. 139:1994;313-326
9. WHO Infection control guidelines for transmissible spongiform encephalopathies. World Health Organization Report 23-26 March 1999, WHO/CDS/CSR/APH/2000.3, 1999.
10. McDonnell G, Burke P. The challenge of prion decontamination. Clin Infect Dis. 36:2003;1152-1154
11. Lee DC, Stenland CJ, Hartwell RC, et al. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. J Virol Methods. 84:2000;77-89
12. Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med. 5:1999;240-243
13. Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J, Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med. 7:2001;679-684
14. Kimberlin RH, Walker C. Characteristics of a short incubation model of scrapie in the golden hamster. J Gen Virol. 34:1977;295-304
15. Adjou KT, Demaimay R, Deslys JP, et al. MS-8209, a water-soluble amphotericin B derivative, affects both scrapie agent replication and PrPres accumulation in Syrian hamster scrapie. J Gen Virol. 80:1999;1079-1085
16. Krause J, McDonnell G, Riedesel H. Biodecontamination of animal rooms and heat-sensitive equipment with vaporized hydrogen peroxide. Contemp Top Lab Anim Sci. 40:2001;18-21
17. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg. 27:1938;493-497
18. Barret A, Tagliavini F, Forloni G, et al. Evaluation of quinacrine treatment for prion diseases. J Virol. 77:2003;8462-8469
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
20. Deslys JP, Comoy E, Hawkins S, et al. Screening slaughtered cattle for BSE. Nature. 409:2001;476-478
21. Ernst DR, Race RE. Comparative analysis of scrapie agent inactivation methods. J Virol Methods. 41:1993;193-201
22. Brown P, Rohwer RG, Green EM, Gajdusek DC. Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus. J Infect Dis. 145:1982;683-687
23. Taylor DM, Fernie K, McConnell I, Steele PJ. Observations on thermostable subpopulations of the unconventional agents that cause transmissible degenerative encephalopathies. Vet Microbiol. 64:1998;33-38
24. Taylor DM. Resistance of the ME7 scrapie agent to peracetic acid. Vet Microbiol. 27:1991;19-24
25. Antloga K, Meszaros J, Malchesky PS, McDonnell GE. Prion disease and medical devices. Asaio J. 46:2000;69-72
26. Kasermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to proteinase K. J Gen Virol. 84:2003;3173-3176
27. Race RE, Raymond GJ. Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH. J Virol. 78:2004;2164-2165